U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269587) titled 'A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19' on Nov. 25.
Brief Summary: This clinical study is a retrospective, observational, and multicenter post marketing real-world study aimed at evaluating the efficacy and safety of CNCT-19 in the treatment of Chinese adult B-cell acute lymphoblastic leukemia patients.
Study Start Date: Nov. 07
Study Type: OBSERVATIONAL
Condition:
ALL (Acute B-Lymphoblastic Leukemia)
CAR-T Cell Therapy
Intervention:
DRUG: CNCT-19
All patients have received CNCT-19
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Ruijin Hospital
Information provided b...